A COVID-19 vaccine developed by AstraZeneca and Oxford University showed average efficacy of 70.4% in a pooled analysis of interim data from late stage trials, Oxford said on Tuesday. Much…

Read more »

The post Oxford-Astra COVID-19 Vaccine Shows Average 70.4% Efficacy in Pooled Study appeared first on Hamodia.

In related news:

  1. ‘A Pretty Scary Thing’: Kid Illness Tied to Virus Worries NY
  2. EU Agency: Coronavirus Vaccine Possible in About a Year
  3. U.S. Revokes Emergency Use of Malaria Drugs vs. Coronavirus
  4. Moderna Set to Start Final-Stage Vaccine Trial in 30,000 People
  5. The View From Inside ‘Overwhelmed’ California Hospitals